LYMPHOBLASTIC LEUKEMIA
Clinical trials for LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for leukemia patients: Chemo-Free approach shows promise
Disease control TerminatedThis study tests adding a targeted drug called inotuzumab ozogamicin (InO) to standard treatment for adults newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The goal is to see if this combination can make the cancer disappear faster an…
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
New drug combo aims to boost leukemia treatment
Disease control OngoingThis early-phase study tests whether adding the drug dasatinib (taken as pills for three days each week) to a standard CAR T-cell therapy (brexucabtagene autoleucel) is feasible and safe for adults with a hard-to-treat type of leukemia. Eight participants will receive the combina…
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 19, 2026 12:00 UTC